{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:37:32Z","timestamp":1792006652208,"version":"4.4.0"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12,1]]},"DOI":"10.1093\/brain\/awx276","type":"journal-article","created":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T15:13:03Z","timestamp":1509981183000},"page":"3128-3138","source":"Crossref","is-referenced-by-count":706,"title":["Clinical presentation and prognosis in MOG-antibody disease: a UK study"],"prefix":"10.1093","volume":"140","author":[{"given":"Maciej","family":"Jurynczyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R","family":"Woodhall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naheed","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosie","family":"Everett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Roca-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Tackley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahd","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Sheard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleel","family":"Chandratre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Hemingway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Isabel","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Waters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Palace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,11,9]]},"reference":[{"key":"key\n\t\t\t\t20180122040240_awx276-B1","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/ana.21916","article-title":"Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease [Internet]","volume":"66","year":"2009","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20180122040240_awx276-B2","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1212\/NXI.0000000000000081","article-title":"Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children [Internet]","volume":"2","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"key\n\t\t\t\t20180122040240_awx276-B3","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1177\/1352458514555785","article-title":"Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease [Internet]","volume":"21","year":"2015","journal-title":"Mult Scler J"},{"key":"key\n\t\t\t\t20180122040240_awx276-B4","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1136\/jnnp-2017-315998","article-title":"Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases","volume":"88","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key\n\t\t\t\t20180122040240_awx276-B5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12974-016-0717-1","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin","volume":"13","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"key\n\t\t\t\t20180122040240_awx276-B6","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome","volume":"13","year":"2016","journal-title":"J Neuroinflammation"},{"key":"key\n\t\t\t\t20180122040240_awx276-B7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/brain\/aww350","article-title":"Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis","volume":"140","year":"2017","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180122040240_awx276-B8","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1212\/NXI.0000000000000163","article-title":"Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS","volume":"2","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"key\n\t\t\t\t20180122040240_awx276-B9","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/brain\/aws109","article-title":"Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the UK and Japan","volume":"135","year":"2012","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180122040240_awx276-B10","first-page":"1","article-title":"Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study","year":"2014","journal-title":"JAMA Neurol"},{"key":"key\n\t\t\t\t20180122040240_awx276-B11","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1212\/WNL.0b013e31826aac4e","article-title":"Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype","volume":"79","year":"2012","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180122040240_awx276-B13","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1177\/1352458513484547","article-title":"International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions","volume":"19","year":"2013","journal-title":"Mult Scler J"},{"key":"key\n\t\t\t\t20180122040240_awx276-B14","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1742-2094-8-184","article-title":"Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders","volume":"8","year":"2011","journal-title":"J Neuroinflamm"},{"key":"key\n\t\t\t\t20180122040240_awx276-B15","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/bmj.1.5445.1265","article-title":"Bladder dysfunction in multiple sclerosis","volume":"1","year":"1965","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180122040240_awx276-B16","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","year":"2011","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20180122040240_awx276-B17","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrneurol.2013.118","article-title":"The spectrum of MOG autoantibody-associated demyelinating diseases","volume":"9","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"key\n\t\t\t\t20180122040240_awx276-B18","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","article-title":"Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders","volume":"82","year":"2014","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180122040240_awx276-B19","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s00415-016-8147-7","article-title":"Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes [Internet]","volume":"263","year":"2016","journal-title":"J Neurol"},{"key":"key\n\t\t\t\t20180122040240_awx276-B20","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1212\/NXI.0000000000000257","article-title":"Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis [Internet]","volume":"3","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"key\n\t\t\t\t20180122040240_awx276-B21","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1212\/NXI.0000000000000089","article-title":"MOG cell-based assay detects non-MS patients with inflammatory neurologic disease","volume":"2","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"key\n\t\t\t\t20180122040240_awx276-B22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","year":"2015","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180122040240_awx276-B23","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica [Internet]","volume":"6","year":"2007","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20180122040240_awx276-B24","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","year":"2006","journal-title":"Neurology"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/140\/12\/3128\/23596118\/awx276.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,22]],"date-time":"2018-01-22T04:09:19Z","timestamp":1516594159000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/brain\/article\/140\/12\/3128\/4608963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,9]]},"references-count":23,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,11,9]]},"published-print":{"date-parts":[[2017,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awx276","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732106136.793538829","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.732106136.793540736","asserted-by":"object"}]},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,12]]},"published":{"date-parts":[[2017,11,9]]}}}